{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:18:39Z","timestamp":1778775519818,"version":"3.51.4"},"reference-count":14,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T00:00:00Z","timestamp":1717718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Medicine"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.clinme.2024.100222","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T05:24:26Z","timestamp":1718169866000},"page":"100222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Reducing the harm associated in treating hyperkalaemia with insulin and dextrose"],"prefix":"10.1016","volume":"24","author":[{"given":"Sara","family":"Abou Sherif","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Katsaiti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Jebb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Banh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachna","family":"Bedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien","family":"Ashby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Corbett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.clinme.2024.100222_bib0001","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0268395","article-title":"Hypoglycaemia due to insulin therapy for the management of hyperkalaemia in hospitalised adults: a scoping review","volume":"17","author":"Chothia","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.clinme.2024.100222_bib0002","unstructured":"Clinical Practice Guidelines Treatment of Acute Hyperkalaemia in Adults. October 2023. [Online]. Available from: https:\/\/ukkidney.org\/sites\/renal.org\/files\/FINAL%20VERSION%20-%20UKKA%20CLINICAL%20PRACTICE%20GUIDELINE%20-%20MANAGEMENT%20OF%20HYPERKALAEMIA%20IN%20ADULTS%20-%20191223.pdf."},{"issue":"1","key":"10.1016\/j.clinme.2024.100222_bib0003","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-79180-7","article-title":"The association of insulin dextrose treatment with hypoglycemia in patients with hyperkalemia","volume":"10","author":"Crnobrnja","year":"2020","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.clinme.2024.100222_bib0004","doi-asserted-by":"crossref","first-page":"284","DOI":"10.12788\/jhm.3145","article-title":"Preventing hypoglycemia following treatment of hyperkalemia in hospitalized patients","volume":"14","author":"Boughton","year":"2019","journal-title":"J Hosp Med"},{"issue":"5","key":"10.1016\/j.clinme.2024.100222_bib0005","doi-asserted-by":"crossref","first-page":"833","DOI":"10.5811\/westjem.2019.7.42996","article-title":"Incidence and causes of iatrogenic hypoglycemia in the emergency department","volume":"20","author":"Chittineni","year":"2019","journal-title":"West J Emerg Med"},{"issue":"3","key":"10.1016\/j.clinme.2024.100222_bib0006","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/jhm.977","article-title":"Incidence of hypoglycemia following insulin-based acute stabilization of hyperkalemia treatment","volume":"7","author":"Schafers","year":"2012","journal-title":"J Hosp Med"},{"issue":"Pt A","key":"10.1016\/j.clinme.2024.100222_bib0007","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.phrs.2016.09.039","article-title":"Emergency management of severe hyperkalemia: guideline for best practice and opportunities for the future","volume":"113","author":"Rossignol","year":"2016","journal-title":"Pharmacol Res"},{"issue":"3","key":"10.1016\/j.clinme.2024.100222_bib0008","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/ckj\/sfu026","article-title":"Hypoglycemia in the treatment of hyperkalemia with insulin in patients with end-stage renal disease","volume":"7","author":"Apel","year":"2014","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.clinme.2024.100222_bib0009","unstructured":"Sodium Zirconium Cyclosilicate for Treating Hyperkalaemia. Technology Appraisal Guidance [TA599]. National Institute For Clinical Excellence. 2019. https:\/\/www.nice.org.uk\/guidance\/ta599\/informationforpublic [Accessed 14th March 2023]."},{"issue":"12","key":"10.1016\/j.clinme.2024.100222_bib0010","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1177\/1060028015607559","article-title":"Incidence of hypoglycemia in patients with low eGFR treated with insulin and dextrose for hyperkalemia","volume":"49","author":"Pierce","year":"2015","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.clinme.2024.100222_bib0011","doi-asserted-by":"crossref","first-page":"e13080","DOI":"10.1111\/ijn.13080","article-title":"Risk factors, prevention and treatment of hypoglycaemia after hyperkalaemia in adult patients using intravenous insulin: an integrative review","volume":"29","author":"Long","year":"2023","journal-title":"Int J Nurs Pract"},{"issue":"6","key":"10.1016\/j.clinme.2024.100222_bib0012","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0272-6386(86)80185-8","article-title":"Profound hyperkalemia without electrocardiographic manifestations","volume":"7","author":"Szerlip","year":"1986","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.clinme.2024.100222_bib0013","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s10557-020-07134-2","article-title":"Effects and safety of a novel oral potassium-lowering drug-sodium zirconium cyclosilicate for the treatment of hyperkalemia: a systematic review and meta-analysis","volume":"35","author":"Zhang","year":"2021","journal-title":"Cardiovasc Drugs Ther"},{"issue":"3","key":"10.1016\/j.clinme.2024.100222_bib0014","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJMoa1411487","article-title":"Sodium zirconium cyclosilicate in hyperkalemia","volume":"372","author":"Packham","year":"2015","journal-title":"N Engl J Med"}],"container-title":["Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211824054071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211824054071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T09:52:03Z","timestamp":1724493123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470211824054071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1470211824054071"],"URL":"https:\/\/doi.org\/10.1016\/j.clinme.2024.100222","relation":{},"ISSN":["1470-2118"],"issn-type":[{"value":"1470-2118","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reducing the harm associated in treating hyperkalaemia with insulin and dextrose","name":"articletitle","label":"Article Title"},{"value":"Clinical Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinme.2024.100222","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2024 Published by Elsevier Ltd on behalf of Royal College of Physicians.","name":"copyright","label":"Copyright"}],"article-number":"100222"}}